NVCT R&D Expense Growth
Nuvectis Pharma Inc · R&D Expense Growth
NVCT R&D Expense Growth
Latest reported40.52%period ending
NVCT FY R&D Growth (YoY) (0.00% → 40.52%)
Latest values, visible window
High-resolution chart · PNG
NVCT r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 40.5248% | |
| -16.0078% | |
| 16.2773% | |
| 38.5752% | |
| 0% | |
| 0% |